424 related articles for article (PubMed ID: 27778141)
1. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
Xin Y; McIntosh E
Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
[TBL] [Abstract][Full Text] [Related]
2. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.
Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J
Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789
[TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
4. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
5. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
6. Convergent and Discriminant Validity of the Barthel Index and the EQ-5D-3L When Used on Older People in a Rehabilitation Setting.
Kaambwa B; Bulamu NB; Mpundu-Kaambwa C; Oppong R
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639614
[TBL] [Abstract][Full Text] [Related]
7. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
8. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
Schrag A; Selai C; Jahanshahi M; Quinn NP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
10. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.
Crossman-Barnes CJ; Sach T; Wilson A; Barton G
Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971
[TBL] [Abstract][Full Text] [Related]
11. Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review.
Gottschalk S; König HH; Nejad M; Dams J
Qual Life Res; 2023 Feb; 32(2):307-329. PubMed ID: 35915354
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the content validity of generic preference-based measures for use in Parkinson's disease.
Kuspinar A; Mate K; Lafontaine AL; Mayo N
Parkinsonism Relat Disord; 2019 May; 62():112-116. PubMed ID: 30685325
[TBL] [Abstract][Full Text] [Related]
13. Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness.
Franklin M; Enrique A; Palacios J; Richards D
Qual Life Res; 2021 Sep; 30(9):2633-2647. PubMed ID: 33835414
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
Young MK; Ng SK; Mellick G; Scuffham PA
Qual Life Res; 2013 Jun; 22(5):1065-72. PubMed ID: 22782690
[TBL] [Abstract][Full Text] [Related]
15. A review of the psychometric properties of generic utility measures in multiple sclerosis.
Kuspinar A; Mayo NE
Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
[TBL] [Abstract][Full Text] [Related]
16. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
Martin A; Meads D; Griffiths AW; Surr CA
Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
[TBL] [Abstract][Full Text] [Related]
17. The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson's Disease.
Ramadhan M; Schrag A;
J Geriatr Psychiatry Neurol; 2023 May; 36(3):225-232. PubMed ID: 36264078
[TBL] [Abstract][Full Text] [Related]
18. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
20. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.
Mulhern B; Pink J; Rowen D; Borghs S; Butt T; Hughes D; Marson A; Brazier J
Value Health; 2017 Apr; 20(4):687-693. PubMed ID: 28408012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]